The Times Online reports that a new company based in Boston, Foundation Medicine, has raised $25 million to develop a "one-stop-shop service for genomic diagnosis of cancer." The company's founders include Broad Institute director Eric Lander as well as Levi Garraway, Matthew Meyerson, and Todd Golub of the Dana Farber Cancer Institute and Harvard Medical School, the paper reports.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.